Renaissance Capital logo

NewAmsterdam Pharma (Frazier Lifesciences Acquisition) Priced, Nasdaq: NAMS

Blank check company formed by Frazier Healthcare Partners targeting the biotech industry (completed 11/23/2022).

Industry: SPAC

First Day Return: +2.8%

Industry: SPAC

We are a newly organized blank check company incorporated on October 7, 2020. While we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to capitalize on the ability of our management team to identify promising opportunities in the biotechnology sector. Our sponsor, Frazier Lifesciences Sponsor LLC, is an affiliate of Frazier Healthcare Partners, founded in 1991 as one of the first healthcare dedicated investment firms, with nearly $4.8 billion raised across 12 institutional funds. Our management team is led by Jamie Topper, M.D., Ph.D., Managing General Partner at Frazier who will serve as Chairman of the Board of Directors and Chief Executive Officer; David Topper, Senior Advisor at Frazier who will serve as Chief Financial Officer; Gordon Empey, Frazier Life Sciences Partner and General Counsel, who will serve as Vice President and General Counsel; and Max M. Nowicki, Senior Associate at Frazier who will serve as Vice President, Acquisitions. Our management team and board members have extensive experience in clinical medicine, drug development, regulatory strategy, and operational and management leadership within academia as well as the healthcare and financial industries.
more less
IPO Data
IPO File Date 11/20/2020
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 12.0
Deal Size ($mm) $120
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 12/08/2020
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $120
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Seattle, WA, United States
Founded 2020
Employees at IPO 4
Website www.frazierhealthcare.com

NewAmsterdam Pharma (Frazier Lifesciences Acquisition) (NAMS) Performance